Epigenetic regulation of neurogenesis

There are three primary mechanisms of epigenetic regulation: histone modifications, DNA methylation, and microRNA (miRNA) expression. Histones Histones keep the DNA of the eukaryotic cell tightly packaged through charge interactions (like molecular "Velcro") between the positive charge on the histone tail and the negative charge of the DNA, as well as between histone tails of nearby nucleosomes. While there are many different types of histone modifications, in neural epigenetics there are two primary mechanisms which have been explored: histone methylation and histone acetylation. Histone Methylation Histone methylation occurs when methyl groups are either added or removed from the histone, altering its structure to expose chromatin and leading to gene activation or deactivation. For example, trimethylation of histone H3 at lysine 4 (H3K4me3) is associated with active gene promoters in neurons, while trimethylation at lysine 27 (H3K27me3) represses genes that maintain stem cell identity. A study conducted in 2020 revealed that the Polycomb repressive complex 2 (PRC2), which deposits H3K27me3, silences genes involved in differentiation, such as Neurog2, to preserve neural stem cell pools in the developing brain. DNA Methylation/Demethylation DNA methylation is the addition of methyl groups to cytosine or adenosine residues on the DNA (forming 5-methylcytosine, typically at CpG sites), whereas demethylation is the removal of these methyl groups, and together they serve as crucial epigenetic processes that influence gene expression. DNA methylation is a more lasting method of gene inactivation than histone modification, though is still reversible in some cases. Active demethylation is mediated by Ten-Eleven Translocation (TET) enzymes, which oxidize 5-methylcytosine to promote DNA repair machinery. A study conducted in 2024 demonstrated that TET3 oxidizes methylated DNA in adult neural stem cells, activating Prox1 to drive hippocampal neurogenesis. Additionally, dynamic DNA methylation by DNMT3A in adult-born neurons is critical for their survival and integration into memory circuits, as shown in a 2020 Nature Neuroscience study. MicroRNAs (miRNAs) MicroRNAs are a small form of non-coding RNA (ncRNA) that often act as "fine-tuning" mechanisms for gene expression by repressing or degrading messenger RNA (mRNA) in neural cells. For instance, miR-9 coordinates the switch from neural progenitor proliferation to differentiation by directly repressing stem cell genes like Hes1 and Tlx, as demonstrated in a 2019 study miRNAs can also act directly with transcription factors to guide neurogenesis. A paper from 2020 revealed that miR-124, the most abundant brain miRNA, promotes adult neurogenesis by targeting mRNAs like PTBP1 and SCP1 to enhance neuronal maturation and synaptic integration. == Embryonic neurogenesis ==

Histone modifications Embryonic neurogenesis is the process by which neurons are generated during the development of an embryo. In the context of cortical development, neural stem cells play a pivotal role by following a precise "inside-out" sequence. Specifically, early in development, these stem cells generate the first-born neurons that settle in the deeper cortical layers. As development progresses, later-born neurons migrate past the earlier ones to form the upper layers of the cortex. This carefully orchestrated timing mechanism, observable both in vitro and in vivo, ensures that the cortex is organized in a structured manner, with older neurons establishing foundational deep layers and newer neurons refining the upper layers.. Similarly, the gene Gfap is repressed during early neurogenesis due to methylation of its STAT3 binding sites. Research published in 2001 demonstrated that DNMT3a maintains Gfap methylation until E14.5, thereby delaying the differentiation of astrocytes. miRNAs Mechanism of miRNAs: Conditional knockout of Dicer (an enzyme essential for miRNA synthesis) in the mouse neocortex reduces cortical size, increases neuronal apoptosis, and disrupts cortical layering. Neuroepithelial and progenitor cells remain unaffected until embryonic day 14 (E14), after which they undergo apoptosis. A 2013 study confirmed that this stage-specific requirement for miRNAs ensures proper cortical development, though the exact miRNAs involved remain unclear. Key miRNAs in Neurogenesis Key miRNAs play essential roles in neurogenesis by finely tuning gene expression to control neuronal differentiation and migration. For example, miR-124, the most abundant CNS miRNA, promotes the transition of subventricular zone progenitors into neuroblasts by suppressing Sox9. A study in 2009 demonstrated that miR-124 directly silences Sox9 via a conserved binding site in its 3'UTR, thereby enabling progression along the neuronal lineage. Another example is miR-9, which is critical for regulating both neuronal differentiation and self-renewal. A study from 2016 found that ectopic expression of miR-9 in the mouse cortex prematurely activates NeuroD1(a pro-neuronal gene) and disrupts neuronal migration by targeting Foxg1. Beyond "Fine-Tuning" Contrary to the idea that miRNAs merely fine-tune gene expression, miR-9 and miR-124 have the remarkable ability to reprogram human fibroblasts into neurons without the need for transcription factors like NeuroD1. A study in 2018 demonstrated that these miRNAs alone can remodel chromatin accessibility at key neuronal loci, such as MAP2 and SYN1, thereby enabling the conversion of fibroblasts into neurons; although this method is somewhat less efficient compared to approaches based on transcription factors. Importantly, these epigenetic mechanisms are not confined to embryonic development. In the adult brain, dynamic DNA methylation, histone modifications, and miRNAs continue to orchestrate neurogenesis in specialized niches like the hippocampal dentate gyrus and subventricular zone. For example, DNMT3a-dependent methylation, along with the activity of miR-124, plays a crucial role in maintaining the balance between neuronal stem cell quiescence and activation. This ongoing regulation is essential for lifelong neural plasticity and cognitive function. == Adult neurogenesis ==

DNA methylation Neurogenesis that persists beyond embryonic development and through adulthood is referred to as adult neurogenesis. An important animal gene involved in the epigenetic regulation of adult neurogensis is the Growth arrest and DNA-damage-inducible, beta (GADD45b) gene, often studied in rodents like mice. Through the demethylation of promoters, GADD45b activates genes such as brain-derived neurotrophic factor (BDNF) and basic fibroblast growth factor (FGF2) which are essential for neural progenitor cell development. Consequently, when there is an upregulation of GADD45b, there is increased expression of BDNF and FGF2 resulting in more neural progenitor cells in adulthood. This process allows for greater expression of target genes like brain-derived neurotrophic factor which are involved in adult neurogenesis. Acetylation is made possible by histone acetyltransferases (HATs), which add acetyl groups to histones, promoting gene expression by loosening chromatin structure. Conversely, histone deacetylases (HDACs) remove acetyl groups, leading to chromatin condensation and gene repression. Histone acetylation plays a key role in the differentiation of nerual stem cells into specific cell types. A notable example is the chromatin regulator BRPF1, which is abundantly expressed in the developing central nervous system. It is crucial for the formation of brain regions such as the neocortex and dentate gyrus of the hippocampus. BRPF1 functions by activating histone acetyltransferases like MOZ, MORF, and HBO1, which drive histone acetylation processes essential for proper neural development. Role of HDAC Inhibitors in Promoting Neurogenesis Histone deacetylase inhibitors (HDACi)—such as valproic acid (VPA) and trichostatin A—can enhance adult neurogenesis by blocking HDAC activity, which promotes the differentiation of adult neural progenitor cells. In neural stem cells, HDAC1 and HDAC2 work with the transcription factor TLX to suppress genes that limit cell proliferation, including the cell cycle inhibitor P21 and the tumor suppressor Pten. This repression supports the self-renewal and proliferation of neural stem cells. However, when HDACs are inhibited—such as by VPA, an antiepileptic drug—it can shift neural stem cells toward neuronal differentiation. Similar to processes seen in embryonic neurogenesis, VPA can also suppresses glial cell differentiation in adult neural stem cells. This effect is likely driven by the upregulation of neuron-specific genes, including neurogenic basic helix-loop-helix (bHLH) transcription factors like NEUROD, NEUROGENIN1, and MATH1. While HDAC inhibition can promote neurogenesis, complete loss of HDAC1 and HDAC2 in neural progenitor cells has the opposite effect, potentially preventing proper neuronal differentiation. Similarly, their loss in oligodendrocyte progenitor cells disrupts oligodendrocyte formation, highlighting that histone deacetylation plays distinct and essential roles at various stages of neural development. MicroRNAs and Post-Transcriptional Regulation of Neurogenesis MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expression at the post-transcriptional level, controlling protein production without altering the DNA sequence. One important microRNA in adult neurogenesis is miR-9, which plays a crucial role in cell differentiation. miR-9 targets the nuclear receptor TLX in adult neurogenesis to promote neural differentiation and inhibit neural stem cell proliferation. It also influences neuronal subtype specification and regulates axonal growth, branching, and targeting in the central nervous system through interactions with HES1, a neural stem cell homeostasis molecule. Another crucial miRNA in adult neurogenesis is miR-124, which promotes cell cycle exit and neuronal differentiation. Several mouse studies have shown that ectopic expression of miR-124 leads to premature differentiation and depletion of neural progenitor cells in the subventricular zone (SVZ), a major adult neurogenic region lining the lateral ventricles. The SVZ continuously generates neuroblasts that migrate to the olfactory bulb, and miR-124 overexpression disrupts this process by forcing early cell cycle exit, ultimately reducing long-term neurogenesis. In addition to miR-9 and miR-124, other miRNAs play essential roles in regulation of adult neurogenesis. miR-137, miR-184 and miR-195 regulate adult neural stem cell proliferation, with their over-expression leading to up-regulated proliferation while their down-regulation leads to a decrease in neuronal proliferation. Methyl-CpG binding protein 1 (MBD1) represses miR-184, a microRNA that promotes the proliferation of adult neural stem/progenitor cells (aNSCs) while inhibiting their differentiation by targeting and downregulating Numblike (Numbl), a protein involved in promoting neuronal differentiation. In adult neurogenesis, MBD1, miR-184, and Numbl function together to balance stem cell maintenance and neuronal output. Similarly, miR-195 forms a negative regulatory loop with MBD1; its inhibition promotes aNSC differentiation, and its levels naturally decrease as differentiation proceeds. Disruptions in MBD1 or miRNA signaling have been linked to neurodevelopmental disorders, mood disorders, and impaired cognitive function, all of which underscore the importance of finely tuned adult neurogenesis. == Astrocyte reprogramming ==

Astrocytes are glial cells that form the blood brain barrier and support the synapse. Unlike neurons, glial cells can alter their cell fate prior to reaching full maturation, and "dedifferentiate" due to epigenetic factors. While dedifferentiation is still possible, the expression of genes Mash1, NeuroG1 and NeuroG2 can reprogram astrocytes into neurons. This made possible by the increased acetylation at the H3K9 and H3K14 residues near the NeuroG1 and NeuroG2 genes, trigger neuron differentiation. Additionally, silencing DNA methylation mechanisms—particularly various DNA methyltransferases—prevents astrocyte progenitor cells from redifferentiating into their original glial cell fate. Repression of DNA methylation is essential to block genes required for astrocyte maturation, maintaining a more plastic, undifferentiated state. Overexpression of the histone methyltransferase Ezh2, which catalyzes tri-methylation at H3K27, represses genes involved in astrocyte maintenance, allowing the cell to retain a neural stem cell-like morphology. This shows that different methyltransferases can either promote or inhibit astrocyte dedifferentiation, depending on their activity. Although Ezh2 alone cannot induce dedifferentiation, it is necessary for the process, as its absence prevents astrocytes from reverting to a progenitor state. Once in this state, expression of NeuroD4 can drive neuronal differentiation, enabling neurogenesis from dedifferentiated astrocytes in the adult brain. == In memory ==

The Growth Arrest and DNA Damage inducible 45 (Gadd45) gene family plays a large role in the hippocampus. Gadd45 facilitates hippocampal long-term potentiation and enhances persisting memory for motor performance, aversive conditioning, and spatial navigation. Additionally, DNA methylation has been shown to be important for activity-dependent modulation of adult neurogenesis in the hippocampus, which is mediated by GADD45b. GADD45b seems to act as a sensor in mature neurons for environmental changes which it expresses through these methylation changes. Studies indicate that histone deacetylase (HDAC) inhibitors, such as Trichostatin A (TSA) and sodium butyrate, enhance long-term potentiation and memory consolidation by promoting chromatin relaxation and increasing gene accessibility. Additionally, histone methylation plays a role in regulating neuronal plasticity. Specifically, H3K4 methylation has been shown to activate memory-related genes, whereas H3K9 and H3K27 methylation are associated with gene repression. The balance of these modifications influences cognitive function and memory retention. These modifications interact dynamically, with H3K4me3 enrichment linked to active transcription and memory consolidation, while H3K27me3-mediated repression prevents aberrant gene activation. MicroRNAs also contribute to the epigenetic regulation of memory. miR-132, in particular, has been found to promote dendritic growth and synaptic plasticity, which are essential for learning processes. Emerging evidence suggests that miR-124 also regulates neuronal excitability by targeting ion channel transcripts, further influencing learning and memory pathways. DNMT1 and DNMT3a are both required in conjunction for learning, memory, and synaptic plasticity. These enzymes contribute to the maintenance of methylation homeostasis, with DNMT3a facilitating de novo methylation of plasticity-related genes while DNMT1 ensures the stability of established epigenetic marks. == Epigenetic dysregulation and neurological disorders ==

Epigenetic dysregulation, or alterations in epigenomic machinery, can cause DNA methylation and histone acetylation processes to go rogue. The epigenetic machinery influences neural differentiation regulation (i.e. neurogenesis) and are also involved in processes related to memory consolidation and learning in healthy individuals. DNA methylation and histone modifications play a critical role in modulating gene expression related to synaptic plasticity, which is essential for learning and memory formation. Epigenetic control of enhancer regions in neurons has been linked to neurodegenerative diseases, particularly Alzheimer's disease, where dysregulated chromatin accessibility contributes to neuronal dysfunction. Notably, chromatin loops that regulate enhancer-promoter interactions appear to be disrupted in neurodegenerative conditions, leading to widespread transcriptional alterations. As aging is the main risk for many neurological disorders, epigenetic dysregulation can in turn lead to alterations on the transcriptional level of genes involved in the pathogenesis of neural degenerative diseases such as Parkinson's disease, Alzheimer's disease, Huntington's disease, schizophrenia, and bipolar disease. DNA hydroxymethylation, a modification mediated by TET enzymes, has recently been implicated in the aging brain. Studies show that global 5-hydroxymethylcytosine (5hmC) levels decline with age, potentially contributing to neurodegeneration through loss of gene activation at critical neuronal loci. Recent studies highlight that epigenetic mutations affecting chromatin regulators can result in widespread transcriptional disruptions, contributing not only to common neurodegenerative diseases but also to rare neurological conditions. These microRNAs have been shown to regulate key neuronal genes involved in synaptic plasticity and neuroinflammation, further linking their dysregulation to cognitive decline in Alzheimer's patients. Epigenetic regulation of enhancer regions in neurons has also been implicated in Alzheimer's disease, with studies showing that chromatin accessibility changes contribute to disease progression by altering transcriptional programs essential for neuronal function. Additionally, recent findings suggest that differential DNA methylation of tau-related genes contributes to tau pathology, another defining feature of Alzheimer's disease. Heavy metals also seem to interfere with epigenetic mechanisms. Specifically in the case of APP, lead exposure earlier in life has been shown to cause a marked over-expression of the APP protein, leading to more amyloid plaque later in life in the aging brain. Studies that look at mice with HD versus the wild type (WT) have shown that specific gene loci (Drd2, Penk1, Actb, and Grin1) decrease in histone acetylation levels, suggesting that a mutation of the Huntington (HTT) gene and its overexpression may be the cause of this epigenetic dysregulation. Additionally, research has demonstrated that mutant HTT can interfere with histone acetyltransferase (HAT) activity, further reducing histone acetylation and leading to widespread transcriptional repression in neurons. The proposed mechanism through which SAHA is speculated to act is through a RANBP2-mediated proteasome degradation model, where HDAC inhibition promotes enhanced clearance of misfolded mutant HTT aggregates. As of 2014, HDACi treatment has not been shown to restore normal expression of neuronal-identity genes. However clinical studies using HDACi are currently ongoing and the results are pending, with the Phase II studies showing promise for safe and tolerable use of several compounds such as phenylbutyrate. Newer approaches are investigating more selective HDAC inhibitors that target specific isoforms, aiming to minimize off-target effects while maximizing therapeutic benefits. Specifically, differential methylation patterns have been identified in genes associated with dopaminergic neuron survival, inflammation, and mitochondrial function, highlighting epigenetic regulation as a key factor in PD pathogenesis. A study from 2015 by Hashizume et al. showed that SHMT2 mRNA levels are significantly reduced in the fibroblasts of old people when compared to younger individuals. The study also further indicated that decreased GCAT and SHMT2 levels of gene expression via shRNA and siRNA, respectively, in the fibroblasts of young patients led to a respiratory chain dysfunction typical for senile individuals-suggesting that an epigenetic mechanism may be the cause for the phenotypic change. These findings reinforce the role of mitochondrial epigenetics in cellular aging and suggest that PD-related mitochondrial dysfunction may, in part, be driven by epigenetic modifications. further research into the area will help uncover any implications that mitochondrial DNA methylation plays in the pathogenesis of PD. The use of dopaminergic neurons that have been isolated from the PD patients indicated that there were increases in acetylation (at H2A, H3 and H4) when compared to the age-control group.)-treated cells and (MPP+)-treated mouse brains showed decreased HDAC levels, as well as in midbrain samples from patients with PD. This is seen potentially due to how MPP+ promotes the breakdown of HDAC1 and HDAC2 via autophagy, a bodily process of cycling out old cells to make room for newer, healthier cells. These results point toward the stress of histone modifications in regard to chromatin remodeling and its implication in the pathogenesis of PD. Further, altered histone deacetylation has been shown to affect key pathways involved in neuroinflammation and dopaminergic neuron survival, contributing to disease progression. This further connects to the common mechanisms involving HDACi in various neurodegenerative diseases. Targeting HDAC6 and Sirt2 has been proposed as a potential neuroprotective strategy, as these enzymes regulate cellular stress responses and cytoskeletal stability in neurons. Bipolar Disorder Bipolar disorders are both highly complex and heritable, which makes it an interesting disorder to examine for epigenetic modifications. DNA methylation, DNA hydroxymethylation, and histone modifications are all capable of contributing to the formation of bipolar disorder. Epigenetic mechanisms can influence key neurotransmitter systems, neuroinflammatory pathways, and circadian rhythm genes, all of which are implicated in bipolar disorder pathophysiology. For example, studies of monozygotic twins revealed that individuals with bipolar disorder had lower methylation of the peptidylprolyl isomerase E-like (PPIEL) gene, which can be attributed to the dopamine transmission. The studies indicated that hypermethylation of SLC6A4, a serotonin transporter gene, is also involved with bipolar disorder. Altered serotonin transporter methylation has been linked to mood instability and antidepressant response in affected individuals. Greater expression of DNA methyltransferase 1 in cortical GABAergic interneurons may enable hypermethylation. Hypermethylation may prompt hydroxymethylation to occur in order to overcompensate for the repressive effects of hypermethylation. The methylation of CpG regions are relevant to bipolar disorders. Patients with bipolar disorder showed lower methylation levels for the CpG region of the KCNQ3 gene, which is responsible for the voltage-gated K+ channel. Since voltage-gated potassium channels regulate neuronal excitability, their dysregulation could contribute to the manic and depressive episodes characteristic of bipolar disorder. Childhood maltreatment contributed to the methylation status of CpG2 III of 5-hydroxytryptamine 3A, which alters how maltreatment affects bipolar disorder. These findings suggest that early-life stressors can leave lasting epigenetic marks that modulate the risk and severity of bipolar disorder later in life. Moreover, therapeutic interventions such as engineered transcription factors could modify chromatin structure to address the epigenetic changes found in those with bipolar disorder. DNA methyltransferase (DNMT) inhibitors and histone deacetylase (HDAC) inhibitors could possibly reverse epigenetic modifications in order to therapeutically address bipolar disorder. HDAC inhibitors have been shown to regulate gene expression patterns involved in mood stabilization, and preclinical studies suggest they may enhance the efficacy of conventional mood stabilizers such as lithium. DNMT inhibitors and HDAC often produces antidepressant-like effects. However, challenges remain in developing targeted epigenetic therapies that can selectively modify aberrant epigenetic marks without widespread off-target effects. == Epigenetic therapies for neurodegenerative and psychiatric disorders ==

Given the growing evidence of epigenetic involvement in neurological and psychiatric disorders, researchers are investigating epigenetic-based therapies. HDAC inhibitors, such as valproic acid and vorinostat, have been explored as potential treatments for Alzheimer's, Parkinson's, and Huntington's diseases due to their ability to enhance gene expression related to neuronal survival and synaptic plasticity. Similarly, DNA methylation inhibitors, such as 5-azacytidine and RG108, are being investigated for their potential to reverse hypermethylation of critical genes in disorders like schizophrenia and Alzheimer's disease. However, challenges remain in developing targeted epigenetic therapies that selectively modify disease-relevant genes without causing widespread epigenetic disruption. MicroRNA-based therapies are also under exploration, with strategies including miRNA mimics to restore deficient microRNAs or miRNA inhibitors (antagomirs) to suppress overexpressed microRNAs in disease contexts. For example, miR-132 mimics have shown promise in restoring synaptic function in Alzheimer's disease models, while miR-137 modulators are being explored for potential schizophrenia treatments. == References ==